 |
Peter Wolpert, CEO and Co-Founder, MSc, MScBA Mr Wolpert serves as a board director of Viscogel AB and Lipopeptide AB. He was the co-founder of Accuro Immunology and Ibility and has ten years experience of strategy/business development, financing and management of start-ups. He has worked as interim CEO, management consultant and biotech entrepreneur since 1999. Previously he was a management consultant with McKinsey & Co. |
 |
Martin Ingman, VP Sales and Marketing, MScBA Mr Ingman has 15 years experience from international marketing and sales positions at Astra, Q-Med and Carema.
|
 |
Kjell Rensfeldt, VP Research & Development, MD, BScBA Dr Rensfeldt has ten years of industrial experience from senior management positions at Biogen Idec AB and Q-Med AB. Dr Rensfeldt also has ten years of clinical experience during which he specialized in Urology. |
 |
Magnus Persson, Chief Financial Officer Mr Persson has twenty years experience as CFO and senior management positions in several companies, ranging from start-ups to listed companies such as Popwire, Panopticon, AT&T, Sendit / Microsoft and Digital Vision. He is board chairman of Visit Technology AB and is one of the founders and partner in Streamson AB. |
 |
Anna Ljung, Business Controller
,
MScBA
Ms Ljung previously worked as an independent consultant in technology licensing and serves as part-time CFO for several portfolio companies to Karolinska Development.
|
|
|
|